Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Globus Medical Inc

GMED ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$78.29

▲ +0.22%

Market Cap $10.51B · Vol 320.35K

Key Metrics

P/E Ratio

20.02

FWD: 14.87

Market Cap

$10.51B

Large Cap

Div Yield

N/A

EPS Growth

+25.65%

YoY

RSI (14)

30.59

Momentum

Beta

0.95

vs Market

52W High

$101.10

22.56% below

52W Low

$54.17

44.53% above

Volume

320.35K

Avg 349.37K

P/B

2.58

Price-to-book

ROE

12.47%

Return on equity

Free Float

99.23%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Globus Medical Inc (GMED) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GMED pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.64%

-3.95%

-2.14%

-13.45%

YTD

-10.33%

+29.86%

+47.97%

-6.45%

Financials & Valuation

TTM · Annual

Total Revenue	$2.94B
Net Income	$537.87M
Revenue Growth (YoY)	+5.94%
Gross Margin	63.39%
Operating Margin	18.30%
Net Profit Margin	18.30%
ROE	12.47%
ROA · ROIC	11.47% · 11.70%

P/E Ratio	20.02
Forward P/E (FY1)	14.87
PEG Ratio	0.05
P/S	4.07
P/B	2.58
P/FCF	20.67
EPS Growth	+25.65%
Outstanding Shares	134.26M

Technical Indicators

50-Day SMA	$80.98
200-Day SMA	$85.89
RSI (14)	30.59
Beta	0.95
52-Week High	$101.10
52-Week Low	$54.17

Volume Today	320.35K
Avg Daily Volume (30D)	349.37K
Relative Volume	0.92x
Volatility (10D)	21.18
Volatility (30D)	29.72
Free Float	99.23%

Analyst Consensus

BUY

Current Price $78.29

Mean Target $103.00

52W Low$54.17 52W High$101.10

Current

Target

$54.17 $101.10

Current Analyst target

+31.56% upside potential · 16 analysts

Identifiers

ExchangeNYSE

FIGIBBG002V87T57

ISINUS3795772082

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.42% MDT Medtronic PLC +1.15% COR Cencora Inc -1.86% 7741.T Hoya Corp -1.31% BDX Becton Dickinson and Co -1.54%

Company Profile

Globus Medical, Inc. is a global musculoskeletal company. The Company provides education and clinical support, and advanced care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. The Company offers a comprehensive portfolio of technologies that address a variety of musculoskeletal pathologies, anatomies, and surgical approaches. It separates its products and services into two major categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, surgical instruments, spinal cord stimulation treatment therapy, and neuromonitoring services, used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery which are advanced computer-assisted intelligent systems designed to enhance a surgeon’s capabilities.